These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2798547)

  • 21. Effect of sumatriptan on external pancreatic secretion and its interaction with endogenous norepinephrine in the rat.
    Nagain-Domaine C; Presset O; Chariot J; Rozé C
    Pancreas; 1999 Jul; 19(1):56-61. PubMed ID: 10416693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the olfactory tubercle in the effects of cocaine, morphine and brain-stimulation reward.
    Kornetsky C; Huston-Lyons D; Porrino LJ
    Brain Res; 1991 Feb; 541(1):75-81. PubMed ID: 2029627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning.
    Mackey WB; van der Kooy D
    Pharmacol Biochem Behav; 1985 Jan; 22(1):101-5. PubMed ID: 2858106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reinforcing properties of the mixed agonist-antagonist buprenorphine as assessed by brain-stimulation reward.
    Hubner CB; Kornetsky C
    Pharmacol Biochem Behav; 1988 May; 30(1):195-7. PubMed ID: 3174743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of fluoxetine pretreatment on the neurochemical changes induced by amfonelic acid combined with spiperone in rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1986 Oct; 38(10):776-7. PubMed ID: 2432213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of dopaminergic/serotonergic reuptake inhibition on maternal behavior, maternal aggression, and oxytocin in the rat.
    Johns JM; Joyner PW; McMurray MS; Elliott DL; Hofler VE; Middleton CL; Knupp K; Greenhill KW; Lomas LM; Walker CH
    Pharmacol Biochem Behav; 2005 Aug; 81(4):769-85. PubMed ID: 15996723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation of the attentional and motivational effects of pimozide on the threshold for rewarding brain stimulation.
    Bird M; Kornetsky C
    Neuropsychopharmacology; 1990 Feb; 3(1):33-40. PubMed ID: 2137697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.
    Sakloth F; Negus SS
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):195-204. PubMed ID: 29528663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons.
    Gudelsky GA; Nwajei EE; Defife K; Nash JF
    Synapse; 1992 Dec; 12(4):304-11. PubMed ID: 1361248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5-HT3 antagonist Y-25130 blocks cocaine-induced lowering of ICSS reward thresholds in the rat.
    Kelley SP; Hodge CW
    Pharmacol Biochem Behav; 2003 Jan; 74(2):297-302. PubMed ID: 12479948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the interaction between ethanol and amfonelic acid.
    Menon MK; Kodama CK; Cummins JT; Von Hungen K
    Neuropharmacology; 1987; 26(2-3):247-53. PubMed ID: 3587533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of rewarding properties of morphine by concurrent chemical stimulation of lateral hypothalamus in rats.
    Zarepour L; Komaki A; Shahidi S; Sarihi A; Haghparast A
    Pharmacol Biochem Behav; 2013 Jun; 107():36-41. PubMed ID: 23583715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.
    Todtenkopf MS; Marcus JF; Portoghese PS; Carlezon WA
    Psychopharmacology (Berl); 2004 Apr; 172(4):463-70. PubMed ID: 14727002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute morphine lowers brain stimulation reward thresholds in rats with depressed or elevated response rates.
    Hine B; Lopez M
    Psychopharmacology (Berl); 1990; 102(3):309-11. PubMed ID: 2251329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit morphine's rewarding effect in rats.
    Katsidoni V; Alexiou P; Fotiadou M; Pelecanou M; Sagnou M; Panagis G
    Psychopharmacology (Berl); 2014 Dec; 231(23):4467-78. PubMed ID: 24838368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of levonantradol on rewarding brain stimulation thresholds in the rat.
    Kucharski LT; Williams JE; Kornetsky C
    Pharmacol Biochem Behav; 1983 Jul; 19(1):149-51. PubMed ID: 6622507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine- and cocaine-induced c-Fos levels in Lewis and Fischer rat strains.
    Grabus SD; Glowa JR; Riley AL
    Brain Res; 2004 Feb; 998(1):20-8. PubMed ID: 14725964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Euphorigenic drugs: effects on the reward pathways of the brain.
    Kornetsky C; Esposito RU
    Fed Proc; 1979 Oct; 38(11):2473-6. PubMed ID: 488370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.